Noninsulinoma pancreatogenous hypoglycemia syndrome: quantitative and immunohistochemical analyses of islet cells for insulin, glucagon, somatostatin, and pancreatic and duodenal homeobox protein.
OBJECTIVE
To present a case of an elderly man with noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) and to determine the pathogenesis of this syndrome.


METHODS
The pancreas of our patient with NIPHS was immunocytochemically stained for insulin-, glucagon-, and somatostatin-secreting cells and pancreatic and duodenal homeobox protein (PDX-1). The clinical findings and morphologic and immunocytochemical analyses of the islets of our patient are described, along with a review of related published reports.


RESULTS
A 78-year-old man presented with hyperinsulinemic hypoglycemia, with episodes unrelated to meals or fasting. An insulinoma could not be localized by preoperative imaging or by intraoperative ultrasonography or palpation. He underwent a 70% distal pancreatectomy. For assessment of the possibility that a nuclear transcription factor regulating islet beta-cell growth and development is overexpressed in this disease and is responsible for diffuse islet hyperfunction and proliferation of beta-cells, pancreatic sections from our patient were stained immunocytochemically for PDX-1, insulin, glucagon, and somatostatin. Morphologic findings were compared with pancreatic sections from normal control patients and normative data reported in the literature. Clinical findings and morphologic analyses were consistent with NIPHS. Islets were arranged in long clusters, both in the pancreatic tissue and in peripancreatic adipose tissue. Islets were small but increased in number, and insulin, glucagon, and somatostatin were present in the islets. The relative intensity of insulin staining was increased in our patient in comparison with that in the control patients, and PDX-1 was not overexpressed.


CONCLUSIONS
The etiopathogenesis of NIPHS in this patient involved (1) an increased number of islets with development of ectopic islets in the peripancreatic adipose tissue; (2) alpha- and delta- as well as beta-cell proliferation; and (3) an early step in the development of the islet not involving overexpression of PDX-1.
Sahloul
Raghda
R
Section of Endocrinology and Metabolism, Department of Medicine, Marshall University, VA Medical Center Medical Service, Huntington, West Virginia 25701-3655, USA.
Yaqub
Nadia
N
Driscoll
Henry K
HK
Leidy
John W
JW
Parkash
Jai
J
Matthews
Kimberly A
KA
Chertow
Bruce S
BS
D000368:Aged; D005934:Glucagon / Q000032:analysis; D050416:Glucagon-Secreting Cells / Q000737:chemistry / Q000473:pathology; D018398:Homeodomain Proteins / Q000032:analysis*; D006801:Humans; D007003:Hypoglycemia / Q000378:metabolism* / Q000473:pathology* / Q000601:surgery; D007150:Immunohistochemistry; D007328:Insulin / Q000032:analysis; D050417:Insulin-Secreting Cells / Q000737:chemistry / Q000473:pathology; D007340:Insulinoma / Q000175:diagnosis; D007515:Islets of Langerhans / Q000737:chemistry* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D010180:Pancreatectomy; D010182:Pancreatic Diseases / Q000378:metabolism* / Q000473:pathology* / Q000601:surgery; D013004:Somatostatin / Q000032:analysis; D019864:Somatostatin-Secreting Cells / Q000737:chemistry / Q000473:pathology; D013577:Syndrome; D015534:Trans-Activators / Q000032:analysis*
D018398:Homeodomain Proteins; D007328:Insulin; D015534:Trans-Activators; C084010:pancreatic and duodenal homeobox 1 protein; D013004:Somatostatin; D005934:Glucagon